BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8739775)

  • 21. QT dispersion in alpha-myosin heavy-chain familial hypertrophic cardiomyopathy mice.
    Bevilacqua LM; Maguire CT; Seidman JG; Seidman CE; Berul CI
    Pediatr Res; 1999 May; 45(5 Pt 1):643-7. PubMed ID: 10231857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long QT interval is not only inherited but is also linked to cardiac hypertrophy.
    Swynghedauw B; Baillard C; Milliez P
    J Mol Med (Berl); 2003 Jun; 81(6):336-45. PubMed ID: 12750820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plan of Action for Inherited Cardiovascular Diseases: Synthesis of Recommendations and Action Algorithms.
    Barriales-Villa R; Gimeno-Blanes JR; Zorio-Grima E; Ripoll-Vera T; Evangelista-Masip A; Moya-Mitjans A; Serratosa-Fernández L; Albert-Brotons DC; García-Pinilla JM; García-Pavía P
    Rev Esp Cardiol (Engl Ed); 2016 Mar; 69(3):300-9. PubMed ID: 26856793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular diagnosis in cardiology].
    Priori SG; Napolitano C
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):1027-32. PubMed ID: 12497872
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetics of congenital heart disease: strategies.
    Feit LR
    Adv Pediatr; 1998; 45():267-92. PubMed ID: 9742305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future in hypertrophic cardiomyopathy: important clues and potential advances from an understanding of the genotype phenotype relationship.
    McKenna WJ
    Ital Heart J; 2000 Jan; 1(1):17-20. PubMed ID: 10868917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective implantation of cardioverter-defibrillators in patients with genetic heart disease and sudden death risk.
    Kamath GS; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():32-40. PubMed ID: 20089485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic rabbit models for cardiac disease research.
    Hornyik T; Rieder M; Castiglione A; Major P; Baczko I; Brunner M; Koren G; Odening KE
    Br J Pharmacol; 2022 Mar; 179(5):938-957. PubMed ID: 33822374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marfan syndrome, hypertrophic cardiomyopathy findings underline avoidance of some sports.
    Goldsmith MF
    JAMA; 1992 Dec 23-30; 268(24):3413-4. PubMed ID: 1460723
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gene therapy in heart diseases].
    Tanner FC; Largiadèr T; Yang Z; Lüscher TF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1784-91. PubMed ID: 10603653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death.
    Kang YJ
    Toxicol Pathol; 2006; 34(1):58-66. PubMed ID: 16507545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Athlete's heart or hypertrophic cardiomyopathy?
    Lauschke J; Maisch B
    Clin Res Cardiol; 2009 Feb; 98(2):80-8. PubMed ID: 18853091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Association of a De Novo CALM2 Mutation With Long QT Syndrome and Hypertrophic Cardiomyopathy.
    Zahavich L; Tarnopolsky M; Yao R; Mital S
    Circ Genom Precis Med; 2018 Oct; 11(10):e002255. PubMed ID: 30354306
    [No Abstract]   [Full Text] [Related]  

  • 34. Physiologic or pathologic hypertrophy: how can we know?
    Lai EJ; Rakowski H
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):919-22. PubMed ID: 24972675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
    Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
    Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy.
    Earle N; Ingles J; Bagnall RD; Gray B; Crawford J; Smith W; Shelling AN; Love DR; Semsarian C; Skinner JR
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1346-51. PubMed ID: 26332198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genetic basis for cardiac remodeling.
    Ahmad F; Seidman JG; Seidman CE
    Annu Rev Genomics Hum Genet; 2005; 6():185-216. PubMed ID: 16124859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different pathophysiology of cardiac hypertrophy in hypertension and hypertrophic cardiomyopathy.
    Takeda A; Takeda N
    J Mol Cell Cardiol; 1997 Nov; 29(11):2961-5. PubMed ID: 9405171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis.
    Samak M; Fatullayev J; Sabashnikov A; Zeriouh M; Schmack B; Farag M; Popov AF; Dohmen PM; Choi YH; Wahlers T; Weymann A
    Med Sci Monit Basic Res; 2016 Jul; 22():75-9. PubMed ID: 27450399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics of the long QT syndrome.
    Keating M
    J Cardiovasc Electrophysiol; 1994 Feb; 5(2):146-53. PubMed ID: 8186885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.